Type Expired CO2 9270, Capnograph
510(k) K895001
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK895001 | Date22 Feb 1990 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- CCK
- Device Class
- Class II
- Regulation
- 21 CFR Part 868.1400
- Advisory Committee
- Anesthesiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 21 Sep 2026
This device is a capnograph designed to measure expired carbon dioxide (CO2) levels. It is used to monitor respiratory gas exchange by analyzing the concentration of CO2 in exhaled breath.
The device is supplied as a reusable instrument and was cleared through the FDA 510(k) process under K895001 with product code CCK. It was reviewed by the Anesthesiology advisory committee and received a substantially equivalent determination on February 22, 1990.
Other devices from S & W Medico Teknik A/S
Questions
AI-generated answers, 21 Sep 2026
What is the TYPE EXPIRED CO2 9270 capnograph used for?
This device measures expired carbon dioxide (CO2) levels in exhaled breath to monitor respiratory gas exchange, providing clinicians with real-time data on a patient's ventilation status during anesthesia or critical care.
Is the TYPE EXPIRED CO2 9270 capnograph reusable or single-use?
The device is supplied as a reusable instrument, meaning it can be cleaned, disinfected, and used multiple times following the manufacturer's reprocessing instructions, reducing long-term costs compared to single-use alternatives.
How was the TYPE EXPIRED CO2 9270 capnograph cleared for market release?
It received clearance through the FDA 510(k) process under submission K895001, with a substantially equivalent determination granted on February 22, 1990, after review by the Anesthesiology advisory committee.